Cathie Wood’s ARK Invest Buys Over 380,000 Shares of Pfizer

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 380,000 shares of Pfizer Inc. (NYSE: PFE) on Wednesday, as the price of this fund was up over 1% in the day’s session. It is also up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 382,231 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $17.6 million. This is only a small fraction of the total holdings. The fund is up about 42% over the past 52 weeks.

Check out all the ARK Invest buys for Wednesday:

FundTickerNameShares
ARKFTDOCTELADOC HEALTH16,089
ARKFZZILLOW2,688
ARKGRPTXREPARE THERAPEUTICS3,200
ARKGPSNLPERSONALIS3,781
ARKGPFEPFIZER382,231
ARKGNVTAINVITAE12,514
ARKGADPTADAPTIVE BIOTECHNOLOGIES800
ARKKFATEFATE THERAPEUTICS1,075
ARKKSGFYSIGNIFY HEALTH189,960
ARKQACICATLAS CREST INVESTMENT144,000
ARKQBLDEBLADE AIR MOBILITY36,482
ARKQSPFRJAWS SPITFIRE ACQUISITION14,879
ARKQKMTUYKOMATSU103,400
ARKQKTOSKRATOS DEFENSE & SECURITY SOLUTIONS41,408
ARKQMKFGMARKFORGED56,216
ARKWGENIGENIUS SPORTS121,401
ARKX6301JPKOMATSU62,800
ARKXACICATLAS CREST INVESTMENT31,000
ARKXPRNT3D PRINTING ETF8,903

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: The 2021 NFL Season Starts Next Week: 5 Champion Stocks Will Benefit


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article